Hepatic Tumor Imaging Using Iron Oxide MRI: Comparison With Computed Tomography, Clinical Impact, and Cost Analysis
Authors:
- John F. SchultzJSJohn F. Schultz
- Jeff D. BellJBJeff D. Bell
- Robert M. GoldsteinRGRobert M. Goldstein
- Joseph A. KuhnJKJoseph A. Kuhn
- Todd M. McCartyTMTodd M. McCarty
- 1 October 1999
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 6 (7) , 691-698
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- LIVER-SPECIFIC MR IMAGING CONTRAST AGENTSRadiologic Clinics of North America, 1998
- Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings.American Journal of Roentgenology, 1996
- Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions.Radiology, 1995
- Hepatic metastases from colorectal cancer: detection and false-positive findings with helical CT during arterial portography.Radiology, 1994
- Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T.Radiology, 1992
- Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging.American Journal of Roentgenology, 1991
- Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver.Radiology, 1988
- Hepatic metastases: randomized, controlled comparison of detection with MR imaging and CT.Radiology, 1987
- Hepatic metastases studied with MR and CT.Radiology, 1985
- Hepatic tumors: magnetic resonance and CT appearance.Radiology, 1984